Surgalign Holdings (SRGA) Tops Q2 EPS by $1.39

Surgalign Holdings (NASDAQ: SRGA) reported Q2 EPS of ($0.86), $1.39 better than the analyst estimate of ($2.25). Revenue for the quarter came in at $20.6 million versus the consensus estimate of $21.13 million.

For earnings history and earnings-related data on Surgalign Holdings (SRGA) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform
• Rothschild Redburn Upgrades Apple (AAPL) to Buy